Friday, May 20, 2022

Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

from Top Health News -- ScienceDaily https://ift.tt/vbSfPCx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The Solar System chose fire over ice from the very beginning

Ancient iron meteorites reveal that some of the Solar System’s first solid bodies were built mostly from tiny heat-forged rock beads called ...